TGFB1 and neoplasm: TGF-β in TIM mediates the transformation between the N1, which involves pro-inflammatory neutrophiles with the capacity to stimulate effector T lymphocytes, and the N2 phenotype, which has pro-tumor activity with immunosuppressive and angiogenic features [79].